TTM
−$309.00M
YoY change
-38.0%
5Y CAGR
+7.1%
Peak year (2021)
$15.12B
Cumulative gross profit
$34.16B
Gross Profit history chart for Moderna (MRNA) from 2016 to 2025
Latest: $1.08B
Gross Profit growth chart for Moderna (MRNA) from 2016 to 2025
Latest: -38.0%
Gross Profit history table for Moderna (MRNA) from 2016 to 2025
| 2025 | $1.08B | -38.0% | −$659.00M | ||
| 2024 | $1.74B | -19.5% | −$420.00M | ||
| 2023 | $2.15B | -84.0% | −$11.30B | ||
| 2022 | $13.46B | -11.0% | −$1.66B | ||
| 2021 | $15.12B | +1878.4% | +$14.35B | ||
| 2020 | $764.21M | +2518.2% | +$735.02M | ||
| 2019 | $29.19M | -73.5% | −$81.02M | ||
| 2018 | $110.21M | -40.5% | −$75.08M | ||
| 2017 | $185.29M | +98.6% | +$92.01M | ||
| 2016 | $93.28M | — | — |
- 2025$1.08B-38.0%
- 2024$1.74B-19.5%
- 2023$2.15B-84.0%
- 2022$13.46B-11.0%
- 2021$15.12B+1878.4%
- 2020$764.21M+2518.2%
- 2019$29.19M-73.5%
- 2018$110.21M-40.5%
- 2017$185.29M+98.6%
- 2016$93.28M—
Gross Profit values are taken from Moderna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current gross profit (TTM) is −$309.00M. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Moderna (MRNA) reported gross profit of $1.08B – plunged 38.0% year-over-year.
Moderna gross profit compound annual growth for the 2020–2025 (5 years) window is +7.1%, with mixed annual results across the window.
Moderna gross profit plunged from $15.12B in 2021 to $1.08B in 2025, a 92.9% drawdown.
The record annual gross profit stands at $15.12B, reached in 2021; the historical low of $29.19M was recorded in 2019.
Moderna Gross Profit by Year
Moderna Gross Profit 2025: $1.08B
Moderna gross profit in 2025 was $1.08B, plunged 38.0% below 2024.
Moderna Gross Profit 2024: $1.74B
2024's gross profit for Moderna came in at $1.74B, declined 19.5% below 2023.
Moderna Gross Profit 2023: $2.15B
Moderna posted gross profit of $2.15B in 2023, plunged 84.0% below 2022.
Moderna Gross Profit 2022: $13.46B
In 2022, Moderna reported gross profit of $13.46B, declined 11.0% below 2021.
Moderna Gross Profit 2021: $15.12B
Moderna gross profit in 2021 was $15.12B.
See more financial history for Moderna (MRNA).
Sector peers by Gross Profit
Healthcare peers of Moderna (MRNA), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation